Cooper Companies (NASDAQ:COO) Stock Rating Upgraded by BNP Paribas

Cooper Companies (NASDAQ:COO - Get Free Report) was upgraded by equities researchers at BNP Paribas from a "hold" rating to a "strong-buy" rating in a research note issued to investors on Tuesday,Zacks.com reports.

Other research analysts have also recently issued research reports about the stock. BNP Paribas Exane upgraded shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 target price for the company in a report on Tuesday. Mizuho reduced their price objective on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 16th. Wells Fargo & Company dropped their price objective on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating for the company in a report on Friday, May 30th. Needham & Company LLC upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price objective for the company in a report on Tuesday, June 17th. Finally, UBS Group upgraded shares of Cooper Companies to a "buy" rating in a report on Tuesday, June 17th. Three analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $96.73.

Cooper Companies Trading Up 2.4%

Cooper Companies stock opened at $73.03 on Tuesday. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The firm has a 50-day moving average price of $74.03 and a two-hundred day moving average price of $81.92. The firm has a market capitalization of $14.60 billion, a price-to-earnings ratio of 35.45, a PEG ratio of 1.74 and a beta of 0.99. Cooper Companies has a 52-week low of $65.00 and a 52-week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating the consensus estimate of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The business had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. During the same quarter in the prior year, the firm earned $0.85 EPS. The firm's quarterly revenue was up 6.3% on a year-over-year basis. Sell-side analysts expect that Cooper Companies will post 3.98 earnings per share for the current year.

Institutional Trading of Cooper Companies

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. lifted its position in Cooper Companies by 15.1% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company's stock valued at $2,194,000 after buying an additional 3,440 shares during the period. DAVENPORT & Co LLC increased its holdings in shares of Cooper Companies by 13.4% during the first quarter. DAVENPORT & Co LLC now owns 4,335 shares of the medical device company's stock valued at $366,000 after acquiring an additional 513 shares in the last quarter. State of Alaska Department of Revenue increased its holdings in shares of Cooper Companies by 3.0% during the first quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company's stock valued at $1,972,000 after acquiring an additional 680 shares in the last quarter. Cerity Partners LLC increased its holdings in shares of Cooper Companies by 6.6% during the first quarter. Cerity Partners LLC now owns 17,113 shares of the medical device company's stock valued at $1,443,000 after acquiring an additional 1,054 shares in the last quarter. Finally, Proficio Capital Partners LLC bought a new position in shares of Cooper Companies during the fourth quarter valued at $95,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.